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Summary pH frequency distributions of tumours grown s.c. from 30 human tumour xenograft lines in
rnu/rnu rats were analysed with the use of H+ ion-sensitive semi-microelectrodes prior to and following
stimulation of tumour cell glycolysis by i.v. infusion of glucose. At normoglycemia, the average pH of the
tumours investigated was 6.83 (range, 6.72-7.01; n = 268). Without exception, all xenografts responded to the
temporary increase in plasma glucose concentration (PGC) from 6 ± 1 to 30 ± 3 mM by an accumulation of
acidic metabolites, as indicated by a pH reduction to an average value of 6.43 (range, 6.12-6.78; n = 292).
This pH value corresponds to a ten-fold increase in H+ ion activity in tumour tissue as compared to arterial
blood. Tumour pH approached minimum values at 2-4 h after the onset of glucose administration and could
be maintained at acidic levels for 24 h by controlled glucose infusion. Irrespective of pH variations between
tumours grown from individual xenograft lines, there was no major difference in pH response to glucose
between the four main histopathological tumour entities investigated, i.e. breast, lung and gastrointestinal
carcinomas, and sarcomas. In tumours from several xenograft lines, an increase in blood glucose to only
2.5-times the normal value (14 mM) was sufficient to reduce the mean pH to 6.4. Glucose-induced acidosis was
tumour-specific. The pH frequency distributions in liver, kidney and skeletal muscle oftumour-bearing rnu/rnu
rats were only marginally sensitive to hyperglycemia (average pH, 6.97 vs normal value of 7.14). Tumour-
selective activation of pH-sensitive anti-cancer agents, e.g. alkylating drugs, acid-labile prodrugs or pH-
sensitive immunoconjugates may thus be feasible in a wide variety of human cancers.
Any attempt to improve the selectivity of anti-cancer agents
must be based on genetic, phenotypic or pathophysiological
differences distinguishing cancer cells and tissues from their
normal counterparts. Molecular alterations underlying the
process of malignant transformation and tumour progression
not only comprise mutations, but also changes in transcrip-
tion of normal genes controlling cellular functions whose
dysregulation is critically associated with the expression of
malignant phenotypes (Schutzbank et al., 1982; Birnbaum et
al., 1987; Busch, 1990). To improve the therapeutic index of
anti-cancer agents strategies are thus being sought that would
exploit such transformation-associated changes by rational
drug design. For example, in malignant cells the expression
of genes coding for membrane-based glucose transporters
and glycolytic enzymes is frequently increased; this molecular
alteration is pivotal to a metabolic hallmark of malignant
cells, aerobic glycolysis (Birnbaum et al., 1987; Flier et al.,
1987). The capacity of cancer cells to metabolise glucose to
lactic acid (Warburg et al., 1924; Aisenberg, 1961; Weber,
1977; Lyon et al., 1988) can be exploited to stimulate lactate
production selectively in malignant tissues. This manipulation
involves a temporary induction of hyperglycemia in tumour-
bearing hosts by i.v. infusion of glucose and results in an
increased activity of H+ ions in malignant tissues (Jahde et
al., 1982b; Wike-Hooley et al., 1984; Ward & Jain, 1988;
Jahde et al., 1989; Hwang et al., 1991). Since H+ ions are
potent modulators of various types of chemical reactions,
tumour-selective acidification can be made use of, in a second
step, to increase the target cell-directed cytotoxicity of anti-
cancer agents, e.g. alkylating drugs, acid-labile prodrugs, pH-
sensitive immunoconjugates, hyperthermia, or acid-labile
liposomes (Jahde et al., 1989; Tietze et al., 1989; Lavie et al.
1991; Hiroaka & Hahn, 1989; Yatvin et al., 1980).
The pathophysiological basis of this approach has so far
been investigated almost exclusively in transplanted rodent
tumours. With the use of invasive as well as noninvasive
techniques for measuring pH, the H+ ion activity in a wide
variety of animal tumours was shown to be increased follow-
ing stimulation of aerobic glycolysis (Wike-Hooley et al.,
1984; Ward & Jain, 1988; Jahde et al., 1982b; Jahde et al.,
1989). We are, however, only aware of few investigations
analysing the H + ion activity in human tumours in situ
following glucose-mediated stimulation of lactic acid produc-
tion (Naeslund & Swenson, 1953; Ashby, 1966; Thistleth-
waite, 1987; Lavie et al., 1991). In these studies, only 25
individual tumours, including ten malignant melanomas, five
female genital cancers and ten tumours of varying histology
were analysed. To establish the prerequisites for clinical trials
with pH-sensitive cytotoxic agents, we are investigating
whether the response of human tumours to stimulation of
aerobic glycolysis is similar to that of transplanted rodent
tumours. As a first step toward this goal we have measured
the H + ion activity in a large panel of human tumour
xenografts with and without induction of hyperglycemia. In
particular, we have investigated (i) whether there are his-
topathological tumour entitites of major clinical importance
which are not responsive to glucose, and (ii) to what extent
individual tumours vary in their pH response. For these
studies, 30 human tumour xenograft lines of diverse his-
togenesis were established in congenitally athymic rats. A
further objective of this work has been to define the level of
hyperglycemia required to reduce the pH in human tumour
tissues to values compatible with tumour-selective activation
of cytotoxic agents (i.e. -0.5 pH units below the value of
normal tissues). In addition, the accumulation of acidic
metabolites in human tumour xenografts was investigated as
a function of tumour mass, tumour growth rate, and the
duration of hyperglycemia.
Materials and methods
Animals
Congenitally athymic rats (body weight, 220 ± 20g) were
used since pilot experiments had indicated that nude mice
were, for technical reasons, less suited for long-term i.v.
infusion via implanted central venous catheters. Male and
female Han:RNU-rnu/rnu rats, 4-6 weeks old, were pur-
chased from Zentralinstitut fur Versuchstierzucht (Hannover,
Germany) and LEW/Mol-rnu/rnu rats of the same age from
M0llegaard Breeding Center (Ejby, Denmark). Rats were
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housed in groups of three on sterile bedding in isolator
cabinets (Altromin, Lage, Germany) at 24°C, 60-70%
humidity and a 12-h light-dark cycle. Animals were fed type
1434 diet (Altromin, Lage, Germany) and had free access to
sterile acidified water (pH 3) supplemented with chlorotetra-
cycline (3 g I').
Tumours
Human tumour xenograft lines, BL, BO, BR, CH, GA, GE,
JE, KO, LA, REI, SE (breast), SE (lung), SP, SCHRO, and
STO, previously grown in nu/nu mice, were re-established
from frozen tissue samples in this species for one passage
before transplantation into rnu/rnu rats. Nude mice bearing
the s.c. implanted xenograft lines CXF 1103, LXFA 289, and
LXFE 211 were kindly provided by Dr H.H. Fiebig (Depart-
ment of Internal Medicine I, University of Freiburg i.Br.,
Germany); mice transplanted with SCLC and SW 707 xeno-
grafts by Dr K. Wayss (German Cancer Research Center,
Heidelberg, Germany); and mice bearing N4 and F8 tumours
by Dr V. Budach (Department of Radiotherapy, University
of Essen Medical School, Essen, Germany). Tumour lines
H-MESO, MRI-H-221, MRI-H-121B, MX-1, and LX-1,
were obtained as frozen tissue samples from the Tumour
Bank of the German Cancer Research Center, Heidelberg,
and transplanted directly into rnu/rnu rats. Xenografts A549,
WiDr, and 791/M were established by s.c. injection of
5 x 10' cultured cells (A549 and WiDr, respectively,
American Type Culture Collection, Rockville, MD, USA;
791/M, Xoma, Berkeley, CA, USA) into rnu/rnu rats. The
histopathological classification of the xenograft lines is
presented in Figures 1 and 3. When mouse xenografts had
reached a size of _1 cm3, animals were sacrificed and
tumour fragments of -8mm3 were transplanted s.c. into
both flanks of rnu/rnu rats. Routinely, all pH measurements
were performed on tumours of the first and second rat
passage. Only BR, F8, H-MESO, MRI-H-221, N4, REI, and
SCLC xenografts were transplanted serially for up to 14
passages in rnu/rnu rats. At the first rat passage, samples of
tumour tissue were fixed in 10% buffered formalin and
stained with hematoxylin-eosin. Tumour sections were
evaluated microscopically to confirm the histopathological
classification communicated by the donors, and to ascertain
that the tumour lines studied did not exhibit signs of tissue
rejection. Tumour growth was monitored by caliper measure-
ments and experiments were performed 9-61 days (mean, 33
days) following tumour transplantation. Unless otherwise
stated, at this time tumour volume ranged between 1.2 and
2.8 cm3.
Glucose administration
All infusions were performed i.v. in unanaesthetised, unre-
strained rats. Central venous catheters were made of
polyethylene tubing (Jahde et al.,1982b). Under light ether
anaesthesia, catheters were advanced into the right atrium via
phlebotomy of the right jugular vein and connected to a
flexible, freely rotating infusion line fixed to the neck of the
animals. The infusion apparatus allowed for free movement
of animals in specially designed glass cages (Jahde et al.,
1982b). Glucose or NaCl solutions were continuously infused
with the aid of standard syringe pumps (Braun Melsungen,
Melsungen, Germany). Routinely, rats were connected to the
infusion apparatus 1 day prior to the experiments. To main-
tain the patency of the catheters, NaCl solution (9 g 1-') was
infused at a rate of 0.5 ml h-' until glucose infusion was
initiated. The rate at which sterile glucose solution (0.4 g
ml-') was infused was adjusted according to the desired
PGC. In order to raise PGC to 30 + 3 mM, the infusion rate
was set to 5.0 ml h-1 initially, and thereafter adjusted individ-
ually for each rat according to PGC determinations at inter-
vals of 0.5-3 h. During steady state hyperglycemia (i.e.
- 1 h
after onset of glucose infusion; PGC 30 ± 3 mM) the rate of
glucose infusion ranged between 2 and 3.5 ml h-' of the
above solution, values corresponding to a glucose load of
61-106 mg kg-' body weight min '. Blood glucose concen-
trations were measured in 20 jtl samples of tail vein blood
with the use of an automated glucose analyser (model ESAT
6660, Eppendorf-Netheler-Hinz, Hamburg, Germany). Since
the kinetics of pH reduction in human tumour xenografts
had not been investigated previously, pH measurements were
performed, unless otherwise stated, at 4 h after PGC had
reached plateau values.
pH measurements
pH values in human tumour xenografts and normal tissues
(liver, kidney, skeletal muscle) of rnu/rnu rats were measured
with the use of glass electrodes incorporated into a 25 gauge
bevelled steel needle (length of the sensing portion, 250,rm;
model 802, Diamond General, Ann Arbor, MI, USA). Due
to the large number of measurements, these semi-micro-
electrodes, which exhibit high mechanical stability, were
preferred over fragile glass microelectrodes (Jahde et al.,
1982a). As previously discussed, pH measurements performed
with electrodes of this size primarily reflect the H+ ion
activity in extracellular fluid, with a small but not precisely
known contribution by intracellular components (Jahde et
al., 1982a). Ag/AgCl electrodes (type 373, Ingold, Frankfurt
a.M., Germany) were used as reference electrodes. These
electrodes were connected to tissues (buffers) via a 2 M KCl
interface and an agar bridge prepared by filling a glass
capillary with an aqueous solution of NaCl (9 g1`) and agar
(10 g 1'; heated to 100°C). A Keithley 616 electrometer
(Keithley Instruments, Cleveland, OH, USA) was used for
signal amplification. The reference unit was tested by connec-
ting a standard pH electrode (type 275; Ingold) to the elec-
trometer. All measurements were performed in an electrically
shielded cage. Electrodes were calibrated at 37°C in
physiological phosphate buffers (pH 5.00, 6.03, 6.83, 7.15,
and 7.33) and recalibrated at intervals of 2 h. Typically,
electrodes exhibited the following sensing properties: slope,
58-60rmV pH-' unit; response time (90%), 10-20s; drift,
0.21 mVh-'.
Tumour-bearing rats were anaesthetised with sodium pen-
tobarbital (Nembutal®, 30yigg-1 body weight; Abbott, Bad
Segeberg, Germany) and immobilised on a heating pad. Rec-
tal temperatures were recorded by thermocouples. When
required, additional heating was provided by infrared irradia-
tion. Immediately prior to measurements, skin and fibrous
tissue overlying tumour surfaces were carefully removed over
an area of _ 10 mm2. Particular care was taken not to
damage blood vessels. The reference capillary was placed on
the tumour surface avoiding tissue compression. pH semi-
microelectrodes were then automatically inserted to a depth
of 5-10 mm (according to tumour size) at a speed of
0.5 mm min-' using mechanically driven remote-control
micromanipulators (Jahde et al., 1982a; Jiihde et al., 1982b).
To improve representative sampling in tumours of >2 g, two
electrodes were mounted in parallel (tip distance, 3-4 mm)
and used simultaneously.
Electrode signals were continuously recorded on a type SE
130 2-channel pen recorder (ABB Goerz Metrawatt, Wien,
Austria). At distances of 0.5 mm, single-point pH values were
calculated assuming linear electrode drift between consecutive
calibrations. For data analyses, signals were digitalised using
a 12 bit A/D converter (Kolter Electronic, Erftstadt,
Germany) and transferred to a personal computer. Data
acquisition, statistical analysis and graphic display were
accomplished with the aid of a specially designed computer
programme. Unless otherwise stated, all pH frequency dis-
tributions, mean values and ranges refer to measurements in
groups of at least eight tumours or to the same number of
recordings in normal tissues.
Liver, kidney and skeletal muscle were used as control
tissues. The technique used for pH measurements in kidney
has been described (Jahde et al., 1982b). In preparation of
liver, care was taken to tightly fix, by tissue glue (Histio-
acryl®, Braun Melsungen, Melsungen, Germany), one liver
lobe to a specially designed metal tray in order to avoid494 T. VOLK et al.
artifacts caused by respiratory movements. Analyses of
skeletal muscle were performed in muscles of the left thigh.
Arterial bloodparameters
To monitor side-effects of high-dose glucose infusion on
hemodynamics, arterial blood pressure was measured by a
pressure-transducer (Peter von Berg, Kirchseeon/Eglharting,
Germany) coupled to a monitor (Sirecust 961, Siemens,
Erlangen, Germany) via a 24G cannula inserted into the
abdominal aorta. Blood drawn from this cannula after 5 min
ofpressure registration was analysed for P02, pCO2, pH, K+,
Na+ and hemoglobin with the use of a standard blood gas
analyser (model 288 Blood Gas System, Ciba Coming Diag-
nostics, Fermwald, Germany). In addition, plasma protein
concentration was determined by an Ektachem DT60
analyser (Kodak, Stuttgart, Germany).
Statistical evaluation
Descriptive statistical parameters (means, s.d.) were cal-
culated and two-sample t-tests were applied to test for
differences in two groups. The Bonferroni adjustment was
used to adjust for multiple testing. P values less than 0.05
were judged to be of significance.
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Results
Thirty human tumour xenograft lines were selected for
this study. The composition of the tumour panel reflected,
to some extent, the incidence of various human histo-
pathological tumour entities. The panel included seven mam-
mary carcinomas, eight lung cancers, four gastrointestinal
tumours, four sarcomas, and seven tumours of diverse histo-
genesis.
H+ ion activity in human tumour xenografts at normal PGC
At normal PGC (6 ± 1 mM), the average pH of all xenografts
investigated was 6.84 (n = 268), with extreme single-point
readings of 6.44 and 7.45, respectively (Figure 1). In single
tumours, local pH values varied within 0.3 to 0.8 units. This
broad overall distribution of pH readings resulted from (i)
local heterogeneities of H+ ion activity in individual tumours,
(ii) inter-tumour pH variations -in xenograft lines, and (iii)
differences in the pH frequency distributions between various
tumour lines (Figure 1). As exemplified by the pH histograms
shown in Figures 2-4, the range ofpH readings in individual
xenograft lines was typically 0.3-0.5 units; the mean pH
values of all lines investigated ranged between 6.71 (lung
cancer SCHRO) and 7.01 (gastric cancer SP) (Figure 1).
There was no major difference between the overall pH fre-
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Figure 1 pH in human tumour xenografts at normal PGC. The vertical line at pH 6.84 indicates the average value of all
single-point measurements recorded in a total of 268 xenografts. Black bars indicate the difference between the former value and
the mean pH of individual tumour xenografts. Of each tumour line, 5-12 individual xenografts were analysed. Hatched area:
physiological range of pH values in arterial blood of tumour-bearing rnu/mu rats.HYPERGLYCEMIA AND pH IN HUMAN TUMOUR XENOGRAFTS 495 A
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Figure 2 Effect of i.v. glucose infusion on H+ ion activity in SW
707 human colon cancer, LA human endometrial carcinoma and
CXF 1103 human colon cancer xenografts: frequency distribu-
tions of single-point pH readings at a, normoglycemia (PGC,
6 ± 1 mM) and b, at 5 h after the initiation of glucose infusion
(PGC, 30± 3 mM). SW 707 colon cancer, a, five tumours,
number of pH readings, 165; b, six tumours, number of pH
readings, 204; LA endometrial carcinoma, a, six tumours, number
of pH readings, 116; b, nine tumours, number of pH readings,
276; CXF 1103 colon cancer, a, six tumours, number of pH
readings, 188; b, nine tumours, number of pH readings, 384.
quency distributions of the four main histopathological
tumour entities investigated (breast, lung and gastrointestinal
carcinomas, and sarcomas). In this sequence, the average pH
values of these entities were 6.79, 6.84, 6.93 and 6.87, respec-
tively).
Effect ofi.v. glucose administration on pH in human tumour
xenografts
All tumours grown from the human xenograft lines inves-
tigated responded to glucose-stimulated aerobic glycolysis by
an increase in intratumoural H+ ion activity. After 5 h of i.v.
infusion of glucose (PGC, 30 ± 3 mM), the average pH of all
tumours analysed was reduced to 6.43 (range of single-point
readings, 5.47-7.16; n = 292, P<0.0001) (Figure 3). The pH
response of single xenograft lines to glucose varied markedly,
with mean values ranging between 6.13 (breast carcinoma
SE) and 6.78 (colon cancer CXF 1103) (Figure 3). pH histo-
grams of three representative tumour lines recorded prior to
and following induction of hyperglycemia are shown in
Figure 2. In general, the glucose-mediated shift of pH histo-
grams to more acidic values was accompanied by a broadening
of the pH frequency distributions. This effect was predom-
inantly due to an increase in the range of pH values in all
individual tumours of a given xenograft line and not to
tumours lacking a pH response to glucose, indicating local
heterogeneities in glucose metabolism as well as substrate and
metabolite transport. In colon cancer SW707, >90% of all
pH readings ranged between 6.8 and 7.0 at normal PGC.
During hyperglycemia, however, single-point pH values as
low as 5.7 were recorded (mean, 6.45, P<0.004) (Figure 2).
Similarly, in normoglycemic endometrial carcinoma LA, the
pH frequency distribution encompassed values between 6.4
and 7.0 (mean, 6.79). However, following stimulation of
aerobic glycolysis, -25% of all pH readings were <6.0
(mean, 6.23, P<0.004) (Figure 2). An example of a xeno-
graft line responding to glucose only moderately is given in
Figure 2. At elevated plasma glucose, the pH frequency
distribution of CXF 1103 tumours was only slightly shifted
to more acidic values (mean, 6.78, P<0.005) as compared to
the pH histogram recorded at normal PGC (mean value,
6.97).
Irrespective of marked differences between individual
xenograft lines, there were only small variations in the overall
pH response to glucose among the main tumour entities
investigated (Table I). On average, the H+ ion activity in all
other tumours investigated was increased by a factor of 3.3
(mean pH, 6.31; normoglycemia: mean pH, 6.83; P<0.0001)
and by a factor of 12 as compared to arterial blood.
Pretreatment pH was not predictive of the response to
glucose. For example, the activity of acidic metabolites in
LXFA 289, a xenograft line exhibiting a low pH at normo-
glycemia (mean, 6.75), decreased only slightly (mean pH,
6.55; not significant) when PGC was raised to 30 ± 3 mM.
Conversely, stomach carcinoma SP, with a mean pretreat-
ment pH near neutrality, responded to glucose by a pH
reduction by >0.6 units (P<0.0001, Figures 1,3). In Figure
4, the glucose-mediated pH shift in individual xenograft lines
is depicted as a function of H+ ion activity at normal PGC.
There was no statistically significant correlation between
these parameters (R =0.205).
Effect ofdifferent levels ofhyperglycemia on HI ion activity in
human tumour xenografts
To investigate the correlation between PGC and tumour pH
in more detail, PGC of rnu/mu rats bearing MRI-H-221
xenografts was elevated to plateau values of 14 + 3, 19 + 3,
or 30 ± 3 mM, respectively, and maintained at these levels for
4 h prior to pH measurements. The highest PGC was chosen
according to studies on human volunteers and cancer
patients in whom PGC levels of 30-35 mM have been
generated safely by i.v. glucose infusion (Lippmann &
Graichen, 1977; Forster, 1987; Krag et al., 1990). An increase
in PGC to only about 2.5 times the normal value
(14 ± 3 mM) was sufficient to cause an acidic pH shift in
MRI-H-221 xenografts from 6.72 to 6.46 (P<0.004; Figure
7). At a PGC of 19 ± 3 mM, the mean intratumoural pH was
6.31 (P<0.05) and a further increase in blood glucose to
27-33 mM only resulted in a small further increment in
tumour acidity (mean pH, 6.19; statistically not significant)
(Figure 5).
Dependence ofintratumouralpH on duration ofhyperglycemia
To investigate the effect of various durations of hyper-
glycemia on the accumulation ofacidic metabolites in human
Table I Effect of hyperglycemia on average pH in human tumour
xenografts of four histopathological types
pH
Histopathological Normoglycemia Hyperglycemiaa
tumour type (PGC, 6± I mM) (PGC, 30± 3 mM)
Breast cancers 6.79 (6.72-6.88)b 6.33 (6.13-6.56)
Lung cancers 6.84 (6.74-7.38) 6.53 (6.29-6.71)
Gastronintestinal 6.93 (6.89-7.54) 6.53 (6.37-6.87)
cancers
Sarcomas 6.85 (6.76-6.95) 6.48 (6.41-6.56)
aIn hyperglycemic tumours, measurements were performed at 4 h
afterPGC had reached aplateau. bMeanvalueswith rangesin brackets.
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Figure 3 H+ ion activity in human tumour xenografts following glucose-mediated stimulation of aerobic glycolysis. pH
measurements were performed at 4 h after PGC was raised to 30 ± 3 mm. Designations as in Figure 1. Total number of tumours,
292.
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Figure 4 Correlation between pretreatment pH values in human
tumour xenografts and pH shifts (A pH) induced by glucose-
mediated stimulation of aerobic glycolysis (PGC, 30 ± 3 mM).
Points represent mean values of single xenograft lines.
Figure 5 Dependence of H+ ion activity in MRI-H-221 human
lung cancer xenografts on the level of hyperglycemia: frequency
distributions of single-point pH readings. PGC, 6 ± 1 mM:
ten tumours; number of pH readings, 339. PGC, 14 + 3 mM:
nine tumours; number of pH readings, 372. PGC, 19 ± 3 mM:
six tumours; number of pH readings, 260. PGC, 30 + 3 mM: 12
tumours; number of pH readings, 500.
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tumour xenografts, a PGC of 30 ± 3 mM was maintained for
2, 4, 7, or 24 h, respectively, in animals bearing SCLC lung
carcinomas or N4 sarcomas. In SCLC xenografts, the mean
pretreatment pH of 6.89 rapidly fell to 6.36 (P<0.0001) at
2 h after PGC had reached a plateau and remained at this
level for another 2 h (mean pH at 4 h, 6.39). During the time
interval up to 24 h, tumour pH increased slightly to a mean
value of 6.46. N4 sarcomas exhibited a somewhat different
response to long-term glucose infusion: following initial pH
shifts from 6.90 to 6.56 (P<0.0001) and 6.51 at 2 and 7 h,
respectively, intratumoural acidity thereafter continued to
increase slightly. At 24 h the pH frequency distribution
exhibited a mean value of 6.45.
Effect of tumour mass andgrowth rate on pH in human
tumour xenografts
The growth of malignant tumours is frequently accompanied
by changes in various histomorphological parameters govern-
ing the vascular and interstitial transport of substrates and
metabolites (Vaupel et al., 1989). To investigate the effects of
these changes on the accumulation of acidic metabolites, pH
values in breast carcinomas REI and mesotheliomas H-MESO
were measured as a function of tumour mass (0.6-15.0 g). At
normal PGC, the mean pH values in individual tumours of
both xenograft lines ranged between 6.5 and 7.0. This dis-
tribution of values was not correlated with tumour mass
(Figure 6). At hyperglycemia (PGC, 30 ± 3 mM) smaller
mesotheliomas tended to be slightly more acidic than larger
tumours of the same type (R = 0.45, P<0.02) whereas
breast cancers REI exhibited an inverse correlation between
tumour mass and mean tumour pH (R = - 0.069; statis-
tically not significant; Figure 6). Conversely, the glucose-
induced downshift of pH was independent of the growth rate
of individual xenograft lines as estimated by the time
required to reach a mean tumour volume of 2 cm3
(R = - 0.33).
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Figure 6 Weight-dependence of H+ ion activity in human breast
cancer REI and mesothelioma H-MESO xenografts at normal
and elevated blood glucose concentrations. 0, Mean pH values
of individual tumours at normoglycemia; 0, mean pH values of
individual tumours at 5 h after the onset of glucose administra-
tion (PGC, 30 ± 3 mM).
Effect ofi. v. administration ofmannitol on pH in human
tumour xenografts
In transplanted rodent tumours, parenteral administration of
glucose is associated with a reduction of tumour blood flow
(Kalmus et al., 1989). A similar decrease of tumour perfusion
can be induced by i.v. administration of the nonmeta-
bolisable sugar mannitol. To investigate whether glucose-
mediated reduction of tumour blood flow contributes to the
acidic pH shift at elevated PGC, rats bearing endometrial
carcinoma LA, lung cancer KO as well as breast cancers CH,
BR and MX-1 were infused with a mannitol solution
(0.2 g ml-') at the same dose rate as animals infused with
glucose (- 130 mg mannitol kg-' body weight min-' initially
and 100 mg mannitol kg-' body weight min-' after 1 h).
Tumour pH was measured at 5 h after initiation of mannitol
infusion. The results are listed in Table II. In all xenograft
lines investigated, mannitol caused only a slight shift of the
pH histograms to move acidic values (on average by 0.04 pH
units; statistically insignificant) whereas glucose administra-
tion resulted in pH reduction by 0.44 units (P<0.0001).
Effect ofi. v. glucose infusion on pH in normal tissues of
tumour-bearing hosts
Due to the size of the pH semi-microelectrodes used and
other technical limitations, pH frequency distributions of
human tumour xenografts could not be compared directly to
pH histograms of the normal rat tissues corresponding to the
respective types of tumours, e.g. mammary gland epithelium.
Instead, pH was measured in three rat organs suited for
insertion of pH semi-microelectrodes: liver, kidney and
skeletal muscle. In contrast to the xenografted tumours, only
a minor reduction of pH was observed in these normal rat
tissues following high-dose i.v. glucose infusion (Table III).
For example, the pH readings recorded in skeletal muscle
covered a range of 6.89-7.54 (mean value, 7.22). This pH
Table II Effect of i.v. mannitol or glucose infusion on pH in human
tumour xenografts
Tumour pHa
Histopathological Untreated
tumour type controls Mannitoib Glucosec
Endometrial 6.79 ± 0.12 6.76 ± 0.09 6.23 ± 0.33
carcinoma LA
Lung cancer KO 6.97 ± 0.12 6.89 ± 0.10 6.64 ± 0.11
Breast cancer BR 6.69 ± 0.11 6.62 ± 0.08 6.40 ± 0.22
Breast cancer CH 6.88 ± 0.12 6.85 ± 0.13 6.48 ± 0.25
Breast cancer MX-1 6.78 ± 0.14 6.77 ± 0.18 6.15 ± 0.27
Mean 6.82 6.78 6.38
aMean values ± s.d. of 8-12 individual tumours per group.
bMeasured at 5 h after the onset of infusion of mannitol solution
(0.2 g ml ') at a rate of 100mg mannitol kg-' body weight min-'.
cMeasured at 5 h after the initiation of glucose infusion (100 mg
glucose kg-' body weight min-'; PGC 30 ± 3 mM).
Table III Effect ofhyperglycemia on pH in normal tissues ofrnu/rnu
rats
pH
Normoglycemia Hyperglycemiaa
Tissue (PGC, 6±1 mM) (PGC, 30 ± 3 mM)
Liver 7.08 (6.79-7.48)b 6.88 (6.64-7.12)
Kidney 7.12 (6.74-7.38) 6.96 (6.68-7.23)
Skeletal muscle 7.22 (6.89-7.54) 7.08 (6.73-7.36)
Mean 7.14 6.97
aInhyperglycemic animals,measurementswereperformedat4 h after
PGC had reached a plateau. bMean values with ranges in brackets.
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frequency distribution showed only a slight shift to the left at
4 h after PGC had been raised to 30± 3 mM (mean pH
value, 7.08; range 6.73-7.36; P<0.05). Similar results were
obtained for kidney (Figure 7) and liver of tumour-bearing
rnu/rnu rats (Table III).
Systemic side effects ofhigh-dose glucose infusion
To confirm the safety of the glucose infusion regimen and
to check for artifacts possibly caused by systemic dis-
turbances induced by osmotic diuresis, we measured blood
pressure, arterial blood gases, hemoglobin and protein con-
centrations as well as serum electrolytes in untreated and
hyperglycemic rats. As summarised in Table IV temporary
hyperglycemia had only marginal effects on hemodynamic
parameters as well as indicators of fluid and electrolyte
homeostasis. The decrease in arterial pCO2 likely most is due
to moderate hyperventilation of hyperglycemic rats (Volk et
al., 1993).
Discussion
Carbohydrate metabolism of malignant cells is characterised
by two distinct features: a high rate of glucose uptake and
the formation of lactic acid. In mammalian cells the uptake
of glucose is accomplished by a family of integral membrane
proteins referred to as glucose transporters (Mueckler et al.,
1985; Gould & Bell, 1990). These proteins display cell type-
specific patterns of expression, hormone-responsiveness and
transport properties (Gould & Bell, 1990). In the process of
malignant transformation, the number of glucose transporter
molecules per cell is frequently upregulated (Birnbaum et al.,
1987; Flier et al., 1987). This overall change is paralleled by
alterations in the normally cell type-specific relative expres-
sion frequencies of various transporter subtypes, in favour of
those transporters which are not insulin-dependent (Yama-
40-
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Figure 7 Effect of i.v. glucose infusion on pH in kidney of
rnu/rnu rats: frequency distributions of single-point pH recor-
dings. a, PGC, 6± 1 mM; 12 kidneys; number of pH readings,
147. b, PGC, 30 3 mM; 13 kidneys; number of pH readings,
153.
Table IV Systemic effects of i.v. glucose infusion
Normoglycemia Hyperglycemia
Parameter (PGC, 6±1 mM) (PGC, 30± 3mM)a
MABPb (mmHg) 98 7c 94 6
P02 (mmHg) 93 ± 4.5 94 ± 2.0
pCO2 (mmHg) 46 0.5 31 ± 0.8
pH 7.36 ± 0.04 7.34 ± 0.05
Hemoglobin (g 1-') 150 ± 9 159 ± 12
Na+ (mmol 1-l) 141 5 142 4
K+ (mmollI') 5.6±0.7 4.8±0.9
Protein (g I-') 58 3 58 4
aMeasured 5 hafter onset ofinfusion ofglucose.bMean arterial blood
pressure. cMean values ± s.d. of 10 animals per group.
moto et al., 1990). As a result, glucose uptake into malignant
cells is no longer regulated according to systemic or cellular
demands, but almost exclusively dictated by the extracellular
concentration ofglucose (Eagle et al., 1958). This property of
cancer cells can be exploited to stimulate glucose uptake and,
consecutively, lactic acid production selectively in malignant
tissues by systemically increasing the concentration ofglucose
in the cellular microenvironment (Von Ardenne & Reitnauer,
1978; Jahde et al., 1982b; Wike-Hooley et al.,1984; Ward &
Jain, 1988; Hwang et al., 1991; Jahde et al., 1989).
Without exception, the human tumour xenografts inves-
tigated in the present study responded to an increased PGC
by an accumulation of acidic metabolites. In individual
tumours, single-point pH readings as low as 5.47 were
recorded. In seven xenograft lines, the mean pH was reduced
below 6.25. On average, intratumoural pH was reduced
to 6.43, a value corresponding to a ten-fold increase in the
activity of H+ ions as compared to arterial blood. This
acidosis was tumour-specific. pH frequency distributions of
liver, kidney and skeletal muscle of tumour-bearing hosts
were only marginally affected by high-dose i.v. glucose
infusion. As discussed previously (Jahde et al., 1982b), these
minor shifts of the pH histograms of normal tissues partly
reflect organ-specific functional changes in tumour-bearing
hosts during hyperglycemia, e.g. increased urine acidity in the
case of kidney.
In view of the potential clinical use of pH-sensitive anti-
cancer agents (Connors et al., 1964; Yatvin et al., 1980;
Wike-Hooley et al., 1984; Ward & Jain, 1988; Lavie et al.,
1991; Hiroaka & Hahn, 1989; Tannock & Rotin, 1989; Tietze
et al., 1989; Jahde et al., 1989), we have analysed various
parameters considered relevant to the design of treatment
protocols. First, we asked whether or not four histo-
pathological tumour entities of major clinical importance
exhibited a similar pH response to glucose. On average, the
pH values of breast, lung and gastrointestinal cancers, and
sarcomas were reduced to 6.36, 6.53, 6.53 and 6.51, respec-
tively, while the mean pH value of all other tumours
analysed was reduced to 6.38. These results indicate that this
manipulation of H+ ion activity may be feasible in most
human tumours requiring systemic treatment. Irrespective of
the tissue of origin, there were, however, differences in the
pH response to glucose between individual xenograft lines
and also between individual tumours derived from a given
xenograft line. For example, in the colon cancer line SW 707
hyperglycemia only reduced the mean pH from 6.98 to 6.78;
but from mean values of 6.73 and 6.77, respectively, to 6.12
and 6.13 in pancreatic carcinoma STO and breast cancer SE.
This hetereogeneity of the pH response, which in individual
tumours could not be predicted from the H+ ion activity at
normoglycemia, is due to cell type-specific differences in the
rate of lactic acid production as well as tissue-specific
differences in the transport of glucose and acidic metabolites.
In Warburg's classical studies on human tumour tissues in
vitro, the metabolic quotient indicating lactic acid production
in the presence of oxygen (aerobic glycolysis), Qc°o2, varied
by a factor of 5 between individual tumours (Warburg et al.,
1924), consistent with recent quantitations of lactate release
from human tumour xenografts in vivo (Kallinowski et al.,
1989). Moreover, tumour blood flow, one of the most impor-
tant determinants of glucose supply as well as lactic acid
clearance, may vary by a factor of 10 among individual
tumours of related histogenesis (Kallinowski et al., 1989). As
shown by Jahde et al. (1992), lactic acid production can be
further increased by additional pharmacological interventions
employing inorganic phosphate and m-iodobenzylguanidine
in those tumours which exhibit only a moderate pH response
to glucose. As demonstrated in N4 sarcomas and SCLC lung
tumours, pH values of -6.45 could be maintained for 24 h,
a time interval exceeding the time required for activation of
various pH-sensitive agents in vitro (Tietze et al., 1989; Jahde
et al., 1989).
In MRI-H-221 xenografts, the mean pH was reduced to
6.46 when PGC was raised to 2.5-times the normal value.
When blood glucose was further incresaed to 19 mM, tumourHYPERGLYCEMIA AND pH IN HUMAN TUMOUR XENOGRAFTS 499
pH continued to decline; however, at PGC levels above
19 mm, the relative increment in acidity gradually levelled off,
with minimum pH values recorded at a PGC of 30 mM. Even
at this level of hyperglycemia no side effects (apart from
osmotic diuresis) requiring interventions were observed as
indicated by stable blood pressure, normal blood gases and
serum electrolytes, a finding consistent with reports by
other investigators (Kruger et al., 1991). In healthy human
volunteers as well as cancer patients, blood glucose levels
ranging between 20 and 30 mM have been generated by
high-dose i.v. glucose infusion (Forster, 1987; Krag et al.,
1990). Given adequate fluid volume replacement, this pro-
cedure was well tolerated. Since insulin secretion is not
compromised in non-diabetic individuals, metabolic derange-
ments characteristic of diabetic ketoacidosis do not occur
following high-dose glucose infusion.
The activity of H+ ions in tumour tissues depends on an
interplay of various determinants. Among these, the rate of
lactic acid production as well as the interstitial and vacular
transport of glucose and lactate are of particular importance.
The predictive value of the results presented here for the pH
response to glucose of human tumours in situ depends,
therefore, on the validity of xenografts as models of cellular
metabolism as well as histomorphological parameters govern-
ing substrate and metabolite transport in tissues. Both in
vitro and in vivo, human tumour cells, with rare exceptions,
respond to elevated extracellular concentrations of glucose by
increased lactic acid production (Naeslund & Swenson, 1953;
Eagle et al., 1958; Aisenberg, 1961; Ashby, 1966; Thistle-
thwaite, 1987; Lavie et al., 1991). It is more difficult to
predict whether acidic metabolites, once their production is
stimulated, will indeed accumulate in human tumours in situ
to a similar extent as observed in human tumour xenografts.
The histomorphology of tumour xenografts does not always
mirror the tissue architecture of primary tumours. In general,
however, the vasculature of xenografted human tumours
bears a high degree of resemblance in morphology as well as
functional properties to the vascular network of primary
tumours in situ (Vaupel et al., 1987; Konerding et al., 1989a;
Konerding et al., 1989b). It may thus be reasonably assumed
that primary tumours will exhibit a similar pH response to
glucose as their xenograft counterparts. This view is sup-
ported by pH measurements in human patients. As stated
above, we are only aware of very few studies that have
measured pH values in human primary tumours following
stimulation of aerobic glycolysis. For example, in Ashby's
series (1966), the average pH of 9 malignant melanomas was
6.57-40 min after PGC had been raised to 23 mM.
pH measurements performed with semi-microelectrodes
primarily reflect H+ ion activities in the extracellular space
although, by destruction of cells, various intracellular com-
partments may contribute to pH readings ('aggregate' pH)
(Jahde et al., 1982b). The cytotoxic effects of pH-sensitive
agents, on the other hand, are either dependent on extracel-
lular or on intracellular H+ ion activity. For example, acid-
labile prodrugs and pH-sensitive immunoconjugates may be
activated in the interstitial space whereas the cytotoxicity of
alkylating drugs and hyperthermia is sensitive to changes in
intracellular pH. Although mammalian cells are able to
maintain pH gradients across plasma membranes, marked
alterations of extracellular pH are accompanied by parallel,
although not fully equivalent shifts of intracellular pH (Tan-
nock & Rotin, 1989; Jahde et al., 1989). The pH
measurements reported here, therefore, are likely to indicate
not only an acidification of tumour interstitial fluid following
stimulation of aerobic glycolysis, but also a shift of intracel-
lular pH. This is supported by measurements of intracellular
pH following stimulation ofaerobic glycolysis with the use of
nuclear magnetic resonance spectroscopy in vitro and in vivo
(Desmoulin et al., 1986J. For example, Hwang et al. (1991)
demonstrated a reduction of predominantly intracellular pH
by 0.79 units in RIF-1 tumours following i.p. glucose
administration. Thus, even though at normoglycemia malig-
nant cells may be capable to maintain the intracellular pH
within normal limits vis-a'-vis a slightly acidic microenviron-
ment (Griffiths, 1991), present evidence suggests that, by
metabolic manipulations, not only the extracellular, but also
intracellular pH can be reduced.
Tumour-selective modification of the cellular microen-
vironment deserves particular attention as a general approach
to the development of more effective treatment modalities for
solid tumours. As indicated by the present study, a selective
increase in H+ ion activity in malignant tissues can be
induced in a wide variety of malignant tumours of diverse
histogenesis. Glucose, the biochemical response modifier
used, in nontoxic (Forster, 1987; Krag et al., 1990).
Moreover, H+ ions are potent modulators of various types of
chemical reactions. Several classes of anti-cancer agents with
different mechanisms of action, as diverse as alkylating
drugs, pH-sensitive immunoconjugates or hyperthermia, have
been identified whose cytotoxicity is sensitive to changes in
microenvironmental pH (Yatvin et al., 1980; Lavie et al.,
1991; Hiroaka & Hahn, 1989; Jahde et al., 1989). Acid-labile
prodrugs of cytotoxic agents have been synthesised which are
stable, and hence nontoxic at physiological pH (Tietze et al.,
1989; Gluisenkamp et al., 1992). At slightly acidic pH, these
prodrugs decompose with the liberation of potent cytotoxic
species. Thus, at pH 6.4 (i.e. the mean pH measured in
human tumour xenografts following glucose-stimulated the
present aerobic glycolysis) the potency of 'second generation'
acid-labile prodrugs, as expressed in terms ofdrug concentra-
tions required to achieve equivalent cell killing in vitro, in-
creases by a factor of 10-20 as compared to pH 7.4
(Gliisenkamp et al., 1992). We believe, therefore, that the
results presented here encourage further exploration of this
approach.
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